Latest debt-to-equity ratio
Monte Rosa Therapeutics Debt-to-equity ratio
Direct answer
Monte Rosa Therapeutics's debt-to-equity ratio is 7.8%.
The verified market snapshot reports 7.8%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 21, 2026.
Get free Monte Rosa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 7.8%
Explore related company data
View Monte Rosa Therapeutics's market capitalizationView Monte Rosa Therapeutics's price-to-book ratioView Monte Rosa Therapeutics's return on equityView Monte Rosa Therapeutics's dividend yieldView Monte Rosa Therapeutics's 52-week price rangeView Monte Rosa Therapeutics's revenue growthView Monte Rosa Therapeutics's profit marginView all Monte Rosa Therapeutics key metricsReturn to Monte Rosa Therapeutics profile